Abstract
Lung cancer is the second most common cause of cancer-related death in the world. Most cases of lung cancer are not curable, especially non-small cell lung cancer (NSCLC). Thus, novel treatment targets for this malignant disease are urgently needed. Here, we demonstrate the feasibility of Rac1 in treating p53-null human NSCLC H1299 as a novel drug target. Deacetylmycoepoxydiene (DA-MED), a cytotoxic natural polyketide, functions as a Rac1 agonist in p53-null NSCLC H1299 cells. DA-MED treatment drives Rac1 activation and promotes robust production of reactive oxygen species, activating mitochondrial permeability transition and the intrinsic apoptotic pathway. Knockdown of Rac1 decreases ROS production in DA-MED-treated cells, resulting in a concomitant decrease in DA-MED-induced apoptosis. DA-MED-activated Rac1 induces autophagy by inhibiting mammalian target of rapamycin, leading to anti-apoptotic and anti-metastatic effects. Therefore, this study provides novel insight into the complex cytotoxic and pro-survival mechanisms associated with a potent Rac1 agonist and suggests that further development of more potent Rac1 agonists could be an effective strategy for future non-small cell lung cancer treatments.
Similar content being viewed by others
References
Alexandrova EM, Yallowitz AR, Li D, Xu S, Schulz R, Proia DA, Lozano G, Dobbelstein M, Moll UM (2015) Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment. Nature 523(7560):352–356. https://doi.org/10.1038/nature14430
Amaravadi R, Kimmelman AC, White E (2016) Recent insights into the function of autophagy in cancer. Genes Dev 30(17):1913–1930. https://doi.org/10.1101/gad.287524.116
Bianco A, Malapelle U, Rocco D, Perrotta F, Mazzarella G (2018) Targeting immune checkpoints in non small cell lung cancer. Curr Opin Pharmacol 40:46–50. https://doi.org/10.1016/j.coph.2018.02.006
Byun JY, Yoon CH, An S, Park IC, Kang CM, Kim MJ, Lee SJ (2009) The Rac1/MKK7/JNK pathway signals upregulation of Atg5 and subsequent autophagic cell death in response to oncogenic Ras. Carcinogenesis 30(11):1880–1888. https://doi.org/10.1093/carcin/bgp235
Daugaard M, Nitsch R, Razaghi B, McDonald L, Jarrar A, Torrino S, Castillo-Lluva S, Rotblat B, Li L, Malliri A, Lemichez E, Mettouchi A, Berman JN, Penninger JM, Sorensen PH (2013) Hace1 controls ROS generation of vertebrate Rac1-dependent NADPH oxidase complexes. Nat Commun 4:2180. https://doi.org/10.1038/ncomms3180
Gazdar AF, Bunn PA, Minna JD (2017) Small-cell lung cancer: what we know, what we need to know and the path forward. Nat Rev Cancer 17:725. https://doi.org/10.1038/nrc.2017.87 https://www.nature.com/articles/nrc.2017.87#supplementary-information
Guo JY, Xia B, White E (2013) Autophagy-mediated tumor promotion. Cell 155(6):1216–1219. https://doi.org/10.1016/j.cell.2013.11.019
Guo JY, Teng X, Laddha SV, Ma S, Van Nostrand SC, Yang Y, Khor S, Chan CS, Rabinowitz JD, White E (2016) Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells. Genes Dev 30(15):1704–1717. https://doi.org/10.1101/gad.283416.116
Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundback T, Nordlund P, Martinez Molina D (2014) The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc 9(9):2100–2122. https://doi.org/10.1038/nprot.2014.138
Jin S, Ray RM, Johnson LR (2006) Rac1 mediates intestinal epithelial cell apoptosis via JNK. Am J Physiol Gastrointest Liver Physiol 291(6):G1137–G1147. https://doi.org/10.1152/ajpgi.00031.2006
Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Hayward NK, Lifton RP, Schlessinger J, Boggon TJ, Halaban R (2012) Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 44(9):1006–1014. https://doi.org/10.1038/ng.2359
Liao H, Zhao X, Qu J, Zhang J, Cai H (2015) Matrine suppresses invasion and metastasis of NCI-H1299 cells by enhancing microRNA-133a expression. Int J Clin Exp Med 8(7):10714–10722
Mizushima N, Yoshimori T, Levine B (2010) Methods in mammalian autophagy research. Cell 140(3):313–326. https://doi.org/10.1016/j.cell.2010.01.028
Montalvo-Ortiz BL, Castillo-Pichardo L, Hernandez E, Humphries-Bickley T, De la Mota-Peynado A, Cubano LA, Vlaar CP, Dharmawardhane S (2012) Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase. J Biol Chem 287(16):13228–13238. https://doi.org/10.1074/jbc.M111.334524
Muller PA, Vousden KH (2014) Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell 25(3):304–317. https://doi.org/10.1016/j.ccr.2014.01.021
Myant KB, Cammareri P, McGhee EJ, Ridgway RA, Huels DJ, Cordero JB, Schwitalla S, Kalna G, Ogg EL, Athineos D, Timpson P, Vidal M, Murray GI, Greten FR, Anderson KI, Sansom OJ (2013) ROS production and NF-kappaB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell 12(6):761–773. https://doi.org/10.1016/j.stem.2013.04.006
Navarro-Lerida I, Pellinen T, Sanchez SA, Guadamillas MC, Wang Y, Mirtti T, Calvo E, Del Pozo MA (2015) Rac1 nucleocytoplasmic shuttling drives nuclear shape changes and tumor invasion. Dev Cell 32(3):318–334. https://doi.org/10.1016/j.devcel.2014.12.019
Potente M, Urbich C, Sasaki K, Hofmann WK, Heeschen C, Aicher A, Kollipara R, DePinho RA, Zeiher AM, Dimmeler S (2005) Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest 115(9):2382–2392. https://doi.org/10.1172/JCI23126
Saci A, Cantley LC, Carpenter CL (2011) Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size. Mol Cell 42(1):50–61. https://doi.org/10.1016/j.molcel.2011.03.017
Shen E, Li Y, Li Y, Shan L, Zhu H, Feng Q, Arnold JM, Peng T (2009) Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes 58(10):2386–2395. https://doi.org/10.2337/db08-0617
Shi Y, Bollam SR, White SM, Laughlin SZ, Graham GT, Wadhwa M, Chen H, Nguyen C, Vitte J, Giovannini M, Toretsky J, Yi C (2016) Rac1-mediated DNA damage and inflammation promote Nf2 tumorigenesis but also limit cell-cycle progression. Dev Cell 39:452–465. https://doi.org/10.1016/j.devcel.2016.09.027
Ueyama T, Geiszt M, Leto TL (2006) Involvement of Rac1 in activation of multicomponent Nox1- and Nox3-based NADPH oxidases. Mol Cell Biol 26(6):2160–2174. https://doi.org/10.1128/MCB.26.6.2160-2174.2006
Ukomadu C, Dutta A (2003) Inhibition of cdk2 activating phosphorylation by mevastatin. J Biol Chem 278(7):4840–4846. https://doi.org/10.1074/jbc.M208658200
Wang J, Zhao B, Zhang W, Wu X, Wang R, Huang Y, Chen D, Park K, Weimer BC, Shen Y (2010) Mycoepoxydiene, a fungal polyketide, induces cell cycle arrest at the G2/M phase and apoptosis in HeLa cells. Bioorg Med Chem Lett 20(23):7054–7058. https://doi.org/10.1016/j.bmcl.2010.09.105
Wang M, Zhang W, Xu W, Shen Y, Du L (2016) Optimization of genome shuffling for high-yield production of the antitumor deacetylmycoepoxydiene in an endophytic fungus of mangrove plants. Appl Microbiol Biotechnol 100(17):7491–7498. https://doi.org/10.1007/s00253-016-7457-0
White E (2016) Autophagy and p53. Cold Spring Harb Perspect Med 6(4):a026120. https://doi.org/10.1101/cshperspect.a026120
Xie W, Zhang L, Jiao H, Guan L, Zha J, Li X, Wu M, Wang Z, Han J, You H (2015) Chaperone-mediated autophagy prevents apoptosis by degrading BBC3/PUMA. Autophagy 11(9):1623–1635. https://doi.org/10.1080/15548627.2015.1075688
Yang WH, Lan HY, Huang CH, Tai SK, Tzeng CH, Kao SY, Wu KJ, Hung MC, Yang MH (2012) RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol 14(4):366–374. https://doi.org/10.1038/ncb2455
Zhan Y, Du X, Chen H, Liu J, Zhao B, Huang D, Li G, Xu Q, Zhang M, Weimer BC, Chen D, Cheng Z, Zhang L, Li Q, Li S, Zheng Z, Song S, Huang Y, Ye Z, Su W, Lin SC, Shen Y, Wu Q (2008) Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nat Chem Biol 4(9):548–556. https://doi.org/10.1038/nchembio.106
Zhang B, Zhang Y, Shacter E (2004) Rac1 inhibits apoptosis in human lymphoma cells by stimulating bad phosphorylation on Ser-75. Mol Cell Biol 24(14):6205–6214. https://doi.org/10.1128/MCB.24.14.6205-6214.2004
Zhang Z, Liang X, Gao L, Ma H, Liu X, Pan Y, Yan W, Shan H, Wang Z, Chen YH, Ma C (2015) TIPE1 induces apoptosis by negatively regulating Rac1 activation in hepatocellular carcinoma cells. Oncogene 34(20):2566–2574. https://doi.org/10.1038/onc.2014.208
Zhu J, Chen Q, Xia X, Mo P, Shen Y, Yu C (2013) Mycoepoxydiene suppresses RANKL-induced osteoclast differentiation and reduces ovariectomy-induced bone loss in mice. Appl Microbiol Biotechnol 97(2):767–774. https://doi.org/10.1007/s00253-012-4146-5
Zhu SS, Zhang YS, Sheng XH, Xu M, Wu SS, Shen YM, Huang YJ, Wang Y, Shi YQ (2015) Deacetyl-mycoepoxydiene, isolated from plant endophytic fungi Phomosis sp. demonstrates anti-microtubule activity in MCF-7 cells. Biomed Pharmacother Biomed Pharmacother 69:82–89. https://doi.org/10.1016/j.biopha.2014.11.020
Zou T, Mao X, Yin J, Li X, Chen J, Zhu T, Li Q, Zhou H, Liu Z (2016) Emerging roles of RAC1 in treating lung cancer patients. Clin Genet 91:520–528. https://doi.org/10.1111/cge.12908
Funding
This work was supported by the National Natural Science Foundation of China (91,313,303, 81,373,304, U1405223), Program for Changjiang Scholars and Innovative Research Team in University (IRT_17R68), the National Natural Science Funds for Distinguished Young Scholars to Y.S. (30325044), and Postdoctoral innovation fund of Shandong Province (201502026).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
ESM 1
(PDF 677 kb)
Rights and permissions
About this article
Cite this article
Xie, W., Zhang, W., Sun, M. et al. Deacetylmycoepoxydiene is an agonist of Rac1, and simultaneously induces autophagy and apoptosis. Appl Microbiol Biotechnol 102, 5965–5975 (2018). https://doi.org/10.1007/s00253-018-9058-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-018-9058-6